Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Featured Stories



Philips Previews Five-Year Plan As Connected Care Returns Group To Growth In Q3

COVID-19 business volatility continues to impact the medtech industry, but Royal Philips is targeting modest comparable sales growth for 2020 after posting quarterly growth of 10%.

Commercial Medical Device Companies

Permitting Initial Virtual Audits Under The MDR: Commission Decision Hangs In The Balance

The European Commission is wavering as pressure builds for it to allow initial audits to be performed virtually under the Medical Device Regulation.

Compliance Enforcement Regulation

Medtronic Announces Two New Trials To Expand TAVR Indications

The SMART trial will compare Medtronic’s Evolut TAVR systems to Edward’s Sapien 3 devices. Evolut EXPAND TAVR I will evaluate Evolut in patients with symptomatic moderate aortic stenosis or asymptomatic severe disease.

Clinical Trials Research & Development Cardiovascular

Merit Medical To Pay $18M To Settle Kickback Case

The US Department of Justice says the company provided advertising assistance and educational grants to health care providers that used its embolization devices.

Commercial Legal Issues Enforcement

Seating Of Barrett On Supreme Court Could Be Death Knell For ACA’s Chronic Illness Coverage

During her confirmation hearings, Judge Amy Coney Barrett denied it’s her goal to end all Affordable Care Act coverage, but some senators and legal experts disagree. And if the ACA is struck down, coverage for chronic disease treated with medical devices – including cancer, heart disease and diabetes – could fall by the wayside.

Policy Legal Issues Reimbursement

Medtronic, The Foundry Invest In New Transcatheter Mitral Repair Technology

The deal gives Medtronic the exclusive right to acquire Half Moon Medical, a start-up developing a mitral valve repair system to compete with Abbott’s MitraClip.

Clinical Trials Deals Cardiovascular

QUOTED. 19 October. Roy Schoenberg.

Amwell’s CEO Roy Schoenberg said during the HLTH virtual conference he foresees a balance between in-patient and digital care with new technologies opening up a “new narrative” to reimagine health care. See what the telehealth company leader said about it here.

Digital Health Telehealth

Infographic: Sleep Apnea Market To Reach Almost $10.3Bn By 2022

The market for devices to monitor and treat sleep apnea and its complications is set to grow by 7.3% annually ...

Device Week Podcast




Discussed in this episode:


Citing Shortages Tied To COVID-19, FDA Allows Some Alternative Flu Test Materials

The agency won’t require a 510(k) if manufacturers make some substitutions for materials now in high demand for COVID-19 tests.

United States FDA


Recent Tweets from Medtech Insight


Latest from PR Newswire


Click here to access further medical device and diagnostics news.


 

Policy & Regulation Explore this Topic

Set Alert for Policy & Regulation

Priority Lane: Guidances On Risky Devices, 510(k) Reform Top FDA’s To-Do List

The US FDA hopes to finalize or issue draft guidance documents on about 30 topics in fiscal year 2021.

Guidance Documents Policy Regulation

Podcast: Impulse Dynamics CEO Says CMS Breakthrough Rule Could Boost R&D (And Is Good Use Of Tax Dollars)

Following the US Medicare agency’s recent proposed rule to give immediate national coverage for breakthrough devices, Simos Kedikoglou spoke with Medtech Insight about what it could mean for companies like his.

Regulation Commercial FDA

Latest From Policy & Regulation

COVID-19 Antigen Tests Offer New Diagnostic Option In Germany

Germany’s COVID-19 testing strategy now permits the use and reimbursement of coronavirus antigen tests.

Germany Coronavirus COVID-19

US Election 2020: Here’s Who Industry’s Donating To

US senatorial friends of the device industry running competitive races in 2020 are being aided by medtech PAC dollars this fall.

Policy Elections

Interview: Diagnostics' Vital Role Is Something to Shout About, Says UK's BIVDA

Diagnosing and mapping COVID-19 are the keys to controlling the pandemic, and the IVDs industry is crucial to their success. But unclear messaging from the center is not helping, says incoming BIVDA chief operating officer Helen Dent.

In Vitro Diagnostics United Kingdom

England’s HTA Body To Overhaul Product Selection Process

Proposals from NICE that are out for consultation are intended to boost the HTA body’s efficiency, improve transparency and governance, and raise the quality of its guidance.

United Kingdom Europe

What You Need to Know About Clinical Evidence For The EU IVDR

With growing urgency for the IVD industry to start compliance with the IVD Regulation, NSF’s Robyn Meurant explains the importance of getting clinical evidence right first time

Europe EU

11 New Telehealth Services Will Be Payable By CMS During Pandemic, Agency Says

The US Medicare agency will allow reimbursements for a bevy of new telemedicine services during the COVID-19 public health emergency, it announced on 14 October.

Policy Medicare

Quality Control & Compliance Explore this Topic

Set Alert for Quality Control

Warning Letter Roundup & Recap – 13 October 2020

Battelle Memorial Institute, which makes its Critical Care Decontamination System under emergency use authorization from the US FDA, was dinged by the agency for Medical Device Reporting violations. It’s the only device-related warning letter released by the FDA over the past week.

Device Warning Letters FDA

US FDA Recognizes Case For Quality Collaborative Community

The Case for Quality Collaborative Community – or CfQcc – affords stakeholders across industry a safe space where they can rally around an array of topics to advance medical device quality and safety.

Quality FDA

Icy HHS/FDA Relations Could Complicate An Already Drawn-Out Quality System Reg Rewrite

A roundup of last month’s top US policy and regulation stories from Medtech Insight: the latest on the US FDA’s Quality System Regulation harmonization efforts; the FDA’s Bakul Patel talks the inevitable future of digital health; a Sanofi usability expert gives a peek at how the company’s conducting human factors studies in the age of COVID-19; and more.

United States Policy

Commercial Explore this Topic

Set Alert for Commercial

HLTH 2020: Amwell CEO Foresees Patient Demand Will Drive Telehealth’s Future

Amwell’s CEO Roy Schoenberg foresees a balance between in-patient and digital care, but risks in telemedicine and regulatory issues remain barriers.

Telehealth Digital Health Artificial Intelligence

Latest From Commercial

Execs On The Move: Spectrawave Welcomes New CEO; e-Therapeutics Promotes Exec To CEO

Former NinePoint Medical CEO takes the helm at Spectrawave; Vigene Biosciences COO heads over from NATRIX Separations; e-Therapeutics executive chairman also takes reigns as CEO; and more.

Commercial Appointments

Medtronic Lays Out Plans To Achieve 5%+ Annual Growth

The medtech giant offered additional details on its ongoing restructuring plan intended to make the company more competitive.

Business Strategies Commercial

Teladoc Sues Amwell Over Alleged Patent Violations Related To Telemedicine Technologies

The legal battle between Teladoc and Amwell heats up as the post-pandemic future of telehealth remains in question. 

Telehealth Legal Issues

US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production

Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.

Coronavirus COVID-19 In Vitro Diagnostics

J&J Bounces Back In Q3, Led By Interventional Devices

Johnson & Johnson’s worldwide medical device revenues grew about 50% sequentially in the third quarter to $6.2bn.

Coronavirus COVID-19 Companies

HLTH 2020: Teladoc And Livongo Say Clients, Doctors Excited About Merger, Cross-Selling Deal With Florida Blue

The CEOs of Teladoc and Livongo said the merged digital health giant will create one-stop shopping for health care.

Telehealth Digital Health

Clinical R&D Explore this Topic

Set Alert for Clinical R&D

Breakthrough Pulmonary Hypertension Treatment To Enter Pivotal Trial Before Year End

IDE trial of SoniVie’s catheter device will be the first for a denervation treatment for PAH.

Clinical Trials Research & Development Cardiovascular

Latest From Research & Development

Medtronic Lays Out Plans To Achieve 5%+ Annual Growth

The medtech giant offered additional details on its ongoing restructuring plan intended to make the company more competitive.

Business Strategies Commercial

Teladoc Sues Amwell Over Alleged Patent Violations Related To Telemedicine Technologies

The legal battle between Teladoc and Amwell heats up as the post-pandemic future of telehealth remains in question. 

Telehealth Legal Issues

US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production

Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.

Coronavirus COVID-19 In Vitro Diagnostics

J&J Bounces Back In Q3, Led By Interventional Devices

Johnson & Johnson’s worldwide medical device revenues grew about 50% sequentially in the third quarter to $6.2bn.

Coronavirus COVID-19 Companies

HLTH 2020: Teladoc And Livongo Say Clients, Doctors Excited About Merger, Cross-Selling Deal With Florida Blue

The CEOs of Teladoc and Livongo said the merged digital health giant will create one-stop shopping for health care.

Telehealth Digital Health

FDA Grants EUA For Access Bio’s Lateral Flow COVID-19 Antigen Test

Access Bio joins Abbott as the second company with FDA authorization to distribute PCR, antigen and antibody tests for COVID-19.

Coronavirus COVID-19 Infectious Diseases
UsernamePublicRestriction

Register